Complement Inhibitor and Enzyme/Protein Replacement Therapy

All criteria may be applied retrospectively and each set identifies prospective application is indicated with an asterisk [*]. The information contained is for the convenience of the public. The Texas Health and Human Services Commission is not responsible for any errors in transmission or any errors or omissions in the document.

  • Revision history
    • April 2022; March 2020; March 2018; March 2017; April 2015; March 2015; Feb. 2013. 
  • Initially developed
    • Dec. 2012